Exeliom Biosciences announces three phase II clinical trials in immuno-oncology with lead candidate pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
While there is very little that is flashy about the French beauty mogul, it s proving an impossible task for any billionaire to dethrone the 70-year-old whose fortune is an estimated $99.5billion.
According to Forbes, French heiress Francoise Bettencourt Meyers is worth $80.5 billion (£64b) having inherited her mother s 33 percent share of the cosmetics company in 2017.
With the latest approval from the EC, patients in Europe suffering from metastatic triple-negative breast cancer can now receive Gilead Science’s Trodlevy as part of their treatment. - News - PharmaTimes